M-NSG

1. Targeting tumor-intrinsic S100 calcium-binding protein A1 augments antitumor immunity and potentiates immunotherapy efficacy
发表年份：2025 来源杂志：Signal Transduction and Targeted Therapy

2. Cytosolic acetyl-coenzyme A is a signalling metabolite to control mitophagy
发表年份：2025 来源杂志：NATURE

3. Prickle4 Drives Microenvironmental Remodeling and Resistance to Parp Inhibition in IDH-Mutant Glioma
发表年份：2025 来源杂志：Advanced Science

4. JMJD3 upregulates ALOX5 to drive malignancy and concomitant ferroptosis sensitivity in gastric cancer
发表年份：2025 来源杂志：Cell Death & Disease

5. Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5
发表年份：2025 来源杂志：Cell Death & Disease

6. Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity
发表年份：2025 来源杂志：MOLECULAR CANCER THERAPEUTICS

7. A collagenase nanogel backpack improves CAR-T cell therapy outcomes in pancreatic cancer
发表年份：2025 来源杂志：Nature Nanotechnology

8. CircABCA1 promotes ccRCC by reprogramming cholesterol metabolism and facilitating M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA
发表年份：2025 来源杂志：Molecular Cancer

9. Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming
发表年份：2025 来源杂志：Cell Metabolism

10. Arachidonic acid triggers spermidine synthase secretion from primary tumor to induce skeletal muscle weakness upon irradiation
发表年份：2025 来源杂志：Cell Metabolism

11. Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
发表年份：2025 来源杂志：Nature Biomedical Engineering

12. Inhibition of tumor cell macropinocytosis driver DHODH reverses immunosuppression and overcomes anti-PD1 resistance
发表年份：2025 来源杂志：IMMUNITY

13. Clinical functional proteomics of intercellular signalling in pancreatic cancer
发表年份：2024 来源杂志：NATURE

14. Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
发表年份：2024 来源杂志：CANCER CELL

15. Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells
发表年份：2024 来源杂志：NATURE MATERIALS

16. An oncolytic virus–T cell chimera for cancer immunotherapy
发表年份：2024 来源杂志：NATURE BIOTECHNOLOGY

17. The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma
发表年份：2024 来源杂志：Cancer Discovery

18. Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation
发表年份：2024 来源杂志：Cell Metabolism

19. Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5
发表年份：2024 来源杂志：Cell Metabolism

20. A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway
发表年份：2024 来源杂志：Molecular Cancer

21. Photo-metallo-immunotherapy: Fabricating Chromium-Based Nanocomposites to Enhance CAR-T Cell Infiltration and Cytotoxicity against Solid Tumors
发表年份：2024 来源杂志：ADVANCED MATERIALS

22. An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti-Solid Tumor Immunity
发表年份：2024 来源杂志：ADVANCED MATERIALS

23. Enhanced engraftment of human haematopoietic stem cells via mechanical remodelling mediated by the corticotropin-releasing hormone
发表年份：2024 来源杂志：Nature Biomedical Engineering

24. Vasopressin drives aberrant myeloid differentiation of hematopoietic stem cells, contributing to depression in mice
发表年份：2024 来源杂志：Cell Stem Cell

25. FLI1 promotes IFN-γ-induced kynurenine production to impair anti-tumor immunity
发表年份：2024 来源杂志：Nature Communications

26. Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors
发表年份：2024 来源杂志：Nature Communications

27. PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma
发表年份：2024 来源杂志：Nature Communications

28. Ultrasound Control of Genomic Regulatory Toolboxes for Cancer Immunotherapy
发表年份：2024 来源杂志：Nature Communications

29. Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice
发表年份：2024 来源杂志：Nature Communications

30. Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia immunity
发表年份：2024 来源杂志：Nature Communications

31. Succinate dehydrogenase deficiency-driven succinate accumulation induces drug resistance in acute myeloid leukemia via ubiquitin-cullin regulation
发表年份：2024 来源杂志：Nature Communications

32. Split-design approach enhances the therapeutic efficacy of ligand-based CAR-T cells against multiple B-cell malignancies
发表年份：2024 来源杂志：Nature Communications

33. ATP6V1D drives hepatocellular carcinoma stemness and progression via both lysosome acidification-dependent and -independent mechanisms
发表年份：2024 来源杂志：Autophagy

34. Protein Kinase STK24 Promotes Tumor Immune Evasion via the AKT-PD-L1 Axis
发表年份：2024 来源杂志：Advanced Science

35. Kidney Organoid Modeling of WT1 Mutations Reveals Key Regulatory Paths Underlying Podocyte Development
发表年份：2024 来源杂志：Advanced Science

36. SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer
发表年份：2024 来源杂志：Advanced Science

37. SKAP1 Expression in Cancer Cells Enhances Colon Tumor Growth and Impairs Cytotoxic Immunity by Promoting Neutrophil Extracellular Trap Formation via the NFATc1/CXCL8 Axis
发表年份：2024 来源杂志：Advanced Science

38. A pan-KRAS degrader for the treatment of KRAS-mutant cancers
发表年份：2024 来源杂志：Cell Discovery

39. ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesis
发表年份：2024 来源杂志：LEUKEMIA

40. Anagrelide and idarubicin combination induces GSDME-mediated pyroptosis as a potential therapy for high-PDE3A acute myeloid leukemia
发表年份：2024 来源杂志：LEUKEMIA

41. Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to quizartinib and gilteritinib
发表年份：2024 来源杂志：CANCER RESEARCH

42. Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma
发表年份：2024 来源杂志：CANCER RESEARCH

43. Adhesion GPCR ADGRE2 Maintains Proteostasis to Promote Progression in Acute Myeloid Leukemia
发表年份：2024 来源杂志：CANCER RESEARCH

44. HDAC6-dependent deacetylation of NGF dictates its ubiquitination and maintains primordial follicle dormancy
发表年份：2024 来源杂志：Theranostics

45. Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease
发表年份：2024 来源杂志：Gut Microbes

46. Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia
发表年份：2024 来源杂志：Cell Reports Medicine

47. Enhancer looping protein LDB1 modulates MYB expression in T-ALL cell lines in vitro by cooperating with master transcription factors
发表年份：2024 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

48. Integrated stress response activation induced by usnic acid alleviates BCL-2 inhibitor ABT-199 resistance in acute myeloid leukemia
发表年份：2024 来源杂志：Journal of Advanced Research

49. Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies
发表年份：2024 来源杂志：Journal of Advanced Research

50. Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia
发表年份：2024 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

51. LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway
发表年份：2024 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

52. iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the multi-copy rDNA locus enhanced antitumor activity and proliferation
发表年份：2024 来源杂志：MedComm

53. Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy
发表年份：2024 来源杂志：JOURNAL OF NANOBIOTECHNOLOGY

54. RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment
发表年份：2024 来源杂志：Journal for ImmunoTherapy of Cancer

55. ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis
发表年份：2024 来源杂志：Journal for ImmunoTherapy of Cancer

56. ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68Ga-labelled cyclic peptides tracers: from bench to bedside
发表年份：2024 来源杂志：Journal for ImmunoTherapy of Cancer

57. Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing
发表年份：2024 来源杂志：MOLECULAR THERAPY

58. Mid1 promotes synovitis in rheumatoid arthritis via ubiquitin-dependent post-translational modification
发表年份：2024 来源杂志：PHARMACOLOGICAL RESEARCH

59. miR-590-3p Overexpression Improves the Efficacy of hiPSC-CMs for Myocardial Repair
发表年份：2024 来源杂志：JACC-Basic to Translational Science

60. Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem Axis
发表年份：2024 来源杂志：International Journal of Biological Sciences

61. LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma
发表年份：2024 来源杂志：Cell Death & Disease

62. Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation
发表年份：2024 来源杂志：Cell Death & Disease

63. Small extracellular vesicle piR-hsa-30937 derived from pancreatic neuroendocrine neoplasms upregulates CD276 in macrophages to promote immune evasion
发表年份：2024 来源杂志：Cancer Immunology Research

64. Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome
发表年份：2024 来源杂志：Cell Reports

65. Small-molecule α-lipoic acid targets ELK1 to balance human neutrophil and erythrocyte differentiation
发表年份：2024 来源杂志：Stem Cell Research & Therapy

66. Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4/MD2 complex formation
发表年份：2024 来源杂志：PHYTOMEDICINE

67. Lactate/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer
发表年份：2024 来源杂志：OncoImmunology

68. PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy
发表年份：2024 来源杂志：Frontiers in Immunology

69. INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib
发表年份：2024 来源杂志：BIOCHEMICAL PHARMACOLOGY

70. The CDK4/6 inhibitor Palbociclib synergizes with ATRA to induce differentiation in AML
发表年份：2024 来源杂志：MOLECULAR CANCER THERAPEUTICS

71. TYM-3-98, a novel selective inhibitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B-cell lymphomas
发表年份：2024 来源杂志：LIFE SCIENCES

72. FAM120A deficiency improves resistance to cisplatin in gastric cancer by promoting ferroptosis
发表年份：2024 来源杂志：Communications Biology

73. IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
发表年份：2024 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

74. ARID5A stabilizes Indoleamine 2,3-dioxygenase expression and enhances CAR T cell exhaustion in colorectal cancer
发表年份：2024 来源杂志：Translational Oncology

75. HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer
发表年份：2024 来源杂志：INTERNATIONAL JOURNAL OF ONCOLOGY

76. Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model
发表年份：2024 来源杂志：EJNMMI Radiopharmacy and Chemistry

77. Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS
发表年份：2024 来源杂志：EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

78. PLA2G2D promotes immune escape in non-small cell lung cancer by regulating T cell immune function through PD-L1-expressing extracellular vesicles
发表年份：2024 来源杂志：SCANDINAVIAN JOURNAL OF IMMUNOLOGY

79. Discovery of Phenylpyrazole Derivatives as a New Class of Selective Inhibitors of MCL-1 with Antitumor Activity
发表年份：2024 来源杂志：ACS Omega

80. FYB1-targeted modulation of CAPG promotes AML progression
发表年份：2024 来源杂志：MOLECULAR AND CELLULAR BIOCHEMISTRY

81. PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome
发表年份：2024 来源杂志：DNA AND CELL BIOLOGY

82. Regional delivery of mesothelin-targeted chimeric antigen receptor T-cell effectively and safely targets colorectal cancer liver metastases in mice
发表年份：2024 来源杂志：Journal of Gastrointestinal Oncology

83. Exosome-derived circCCAR1 promotes CD8+T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
发表年份：2023-03-18 来源杂志：Molecular Cancer

84. Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma
发表年份：2023-03-12 来源杂志：International Journal of Molecular Sciences

85. A novel antidiuretic hormone governs tumour-induced renal dysfunction
发表年份：2023 来源杂志：NATURE

86. Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals
发表年份：2023 来源杂志：CELL

87. Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-β growth-suppressive signaling in BCR-ABL1-positive leukemia
发表年份：2023 来源杂志：Signal Transduction and Targeted Therapy

88. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
发表年份：2023 来源杂志：Molecular Cancer

89. Tumors evade immune cytotoxicity by altering the surface topology of NK cells
发表年份：2023 来源杂志：NATURE IMMUNOLOGY

90. Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress
发表年份：2023 来源杂志：GASTROENTEROLOGY

91. Bone marrow immune cells respond to fluctuating nutritional stress to constrain weight regain
发表年份：2023 来源杂志：Cell Metabolism

92. The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation
发表年份：2023 来源杂志：Cellular & Molecular Immunology

93. STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2
发表年份：2023 来源杂志：NATURE CELL BIOLOGY

94. Cyclosporine A-resistant CAR-T cells mediate antitumour immunity in the presence of allogeneic cells
发表年份：2023 来源杂志：Nature Communications

95. SCARB2 drives hepatocellular carcinoma tumor initiating cells via enhanced MYC transcriptional activity
发表年份：2023 来源杂志：Nature Communications

96. Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia
发表年份：2023 来源杂志：Nature Communications

97. Sequence-based drug design as a concept in computational drug design
发表年份：2023 来源杂志：Nature Communications

98. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models
发表年份：2023 来源杂志：Nature Communications

99. Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors
发表年份：2023 来源杂志：Cancer Communications

100. Enhancement of CAR-T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins
发表年份：2023 来源杂志：Cancer Communications

101. Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling
发表年份：2023 来源杂志：JOURNAL OF CLINICAL INVESTIGATION

102. Cell autonomous expression of BCL6 is required to maintain lineage identity of mouse CCR6+ ILC3s
发表年份：2023 来源杂志：JOURNAL OF EXPERIMENTAL MEDICINE

103. CAR-Aptamers Enable Traceless Enrichment and Monitoring of CAR-Positive Cells and Overcome Tumor Immune Escape
发表年份：2023 来源杂志：Advanced Science

104. NIRF/PET imaging of γδ T cells via metabolic glycoengineering and bioorthogonal labeling
发表年份：2023 来源杂志：CHEMICAL ENGINEERING JOURNAL

105. Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA-Seq
发表年份：2023 来源杂志：Advanced Science

106. Targeted therapy of central nervous system acute lymphoblastic leukemia with an integrin α6-targeted self-assembling proapoptotic nanopeptide
发表年份：2023 来源杂志：Engineering

107. Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis
发表年份：2023 来源杂志：Gut Microbes

108. Transcription factor Nkx2-3 maintains the self-renewal of hematopoietic stem cells by regulating mitophagy
发表年份：2023 来源杂志：LEUKEMIA

109. TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability
发表年份：2023 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

110. Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti–PD-1 Immunotherapy
发表年份：2023 来源杂志：CANCER RESEARCH

111. PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer.
发表年份：2023 来源杂志：CANCER RESEARCH

112. Faecalibacterium prausnitzii abrogates intestinal toxicity and promotes tumor immunity to increase the efficacy of dual CTLA-4 and PD-1 checkpoint blockade
发表年份：2023 来源杂志：CANCER RESEARCH

113. Targeted glycan degradation potentiates cellular immunotherapy for solid tumors
发表年份：2023 来源杂志：PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

114. Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia
发表年份：2023 来源杂志：Biomarker Research

115. TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
发表年份：2023 来源杂志：JOURNAL OF NANOBIOTECHNOLOGY

116. DNAJC10 maintains survival and self-renewal of leukemia stem cells through PERK branch of the unfolded protein response
发表年份：2023 来源杂志：HAEMATOLOGICA

117. T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
发表年份：2022-07-26 来源杂志：nature communications

118. A Chimeric Conjugate of Antibody and Programmable DNA Nanoassembly Smartly Activates T cell for Precise Cancer Cell Targeting
发表年份：2022-06-24 来源杂志：A Journal of the Gesellschaft Deutscher Chemiker

119. BSA-AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma
发表年份：2022 来源杂志：ADVANCED MATERIALS

120. Synthetic libraries of immune cells displaying a diverse repertoire of chimaeric antigen receptors as a potent cancer immunotherapy
发表年份：2022 来源杂志：Nature Biomedical Engineering

121. T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
发表年份：2022 来源杂志：Nature Communications

122. Malfunction of airway basal stem cells plays a crucial role in pathophysiology of tracheobronchopathia osteoplastica
发表年份：2022 来源杂志：Nature Communications

123. Modeling Human Thyroid Development by Fetal Tissue-Derived Organoid Culture
发表年份：2022 来源杂志：Advanced Science

124. Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis Pathways
发表年份：2022 来源杂志：Advanced Science

125. Nano-Biohybrid DNA Engager That Reprograms the T-Cell Receptor
发表年份：2022 来源杂志：Journal of the American Chemical Society

126. Therapeutic strategies targeting uPAR potentiate anti–PD-1 efficacy in diffuse-type gastric cancer
发表年份：2022 来源杂志：Science Advances

127. Heliangin acts as a covalent ligand of RPS2 that disrupts pre-rRNA metabolic processes in NPM1-mutated acute myeloid leukemia
发表年份：2022 来源杂志：Acta Pharmaceutica Sinica B

128. An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ
发表年份：2022 来源杂志：MOLECULAR THERAPY

129. Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction
发表年份：2022 来源杂志：LEUKEMIA

130. FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer
发表年份：2022 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

131. Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL
发表年份：2022 来源杂志：CELL DEATH AND DIFFERENTIATION

132. Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography
发表年份：2022 来源杂志：EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

133. Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model
发表年份：2021-03-11 来源杂志：Front. Immunol

134. Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis
发表年份：2021-01-08 来源杂志：Cancers

135. Liver type 1 innate lymphoid cells develop locally via an interferon-γ–dependent loop
发表年份：2021 来源杂志：SCIENCE

136. A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
发表年份：2021 来源杂志：Science Translational Medicine

137. The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability
发表年份：2021 来源杂志：MOLECULAR CELL

138. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase
发表年份：2021 来源杂志：HEPATOLOGY

139. DMDRMR-Mediated Regulation of m6A-Modified CDK4 by m6A Reader IGF2BP3 Drives ccRCC Progression
发表年份：2021 来源杂志：CANCER RESEARCH

140. Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
发表年份：2021 来源杂志：CLINICAL CANCER RESEARCH

141. WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit
发表年份：2021 来源杂志：Acta Pharmaceutica Sinica B

142. TIGIT-Fc Promotes Antitumor Immunity
发表年份：2021 来源杂志：Cancer Immunology Research

143. 4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells
发表年份：2020-11-13 来源杂志：Frontiers in Immunology

144. SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation
发表年份：2020-05-19 来源杂志：NAT COMMUN

145. Peptide Self-Assembly Nanoparticles Loaded with Panobinostat to Activate Latent Human Immunodeficiency Virus
发表年份：2019-05-01 来源杂志：J Biomed Nanotechnol